ArticleCirculation reports2026

Real-World Low-Density Lipoprotein Cholesterol Control After Transitioning From Evolocumab to Inclisiran.

Tatsuya Tabata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.